Alpine Global Management, LLC Nektar Therapeutics Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.9 - $1.83 $157,651 - $320,557	175,168 New	175,168 $217,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $111,775 - $235,665	55,062 New	55,062 $124,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $32,334 - $62,934	10,200 New	10,200 $39,000
Q2 2018 Aug 15, 2018	SELL	$46.25 - $104.45 $827,273 - $1.87 Million	-17,887 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$57.4 - $108.44 $1.03 Million - $1.94 Million	17,887 New	17,887 $1.9 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $152M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.